HeartSciences COO and director Mark Hilz dies; company won’t replace role soon

Reuters04-04 05:15
HeartSciences COO and director Mark Hilz dies; company won’t replace role soon
  • HeartSciences COO, corporate secretary, director Mark Hilz died April 1, 2026, at age 67.
  • Hilz served on board since 2013.
  • He held COO and corporate secretary roles since March 2022.
  • HeartSciences does not plan to hire a new COO or replace role in foreseeable future.
  • Company expects no change to operations or planned commercialization of MyoVista Insights platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-040032), on April 03, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment